亚洲第一品牌威尼斯澳门人[中国]精粹研究院|官网


公司研发团队在全球顶级学术期刊《Nature Materials》《Nature Communications、《Cell Research等系列发表“载药囊泡治疗肿瘤技术”相关文章20余篇,引用次数高达4000余次,最高单篇影响因子达38以上。


2020.07
题为
Chemotherapeutic Tumor Microparticles Elicit a Neutrophil Response Targeting Malignant Pleural Effusions在 Cancer Immunology Research 杂志上发表。 (IF: 8.728 )


2020.07
题为
Mobilization of neutrophils by MTX-packaging tumor microparticles confers treatment efficacy for obstructive cholangiocarcinoma Nature Biomedical Engineering杂志上发表。 (IF: 18.952 )


2019.10
题为
Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1β Cellular & Molecular Immunology 杂志上发表。 (IF: 8.484)


2019.05
题为
The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency Nature Biomedical Engineering 杂志上发表。 (IF: 18.952) 

2019.01
题为
Autologous tumor cell–derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion 在 Science Translational Medicine 杂志上发表。 (IF: 16.304) 
2018.09
2018.09
题为Mechanisms underlying presentation of tumor microparticle antigens to CD8+ T cells by dendritic cells在 Cancer Immunology Research 杂志上发表。(IF: 8.728
2017.03
2017.01
2017.01
2016.06
2016 .05
2016 .02
2015 .05
题为Tumor cell-derived microparticles: a new form of cancer vaccine在 Oncoimmunology 杂志上发表。(IF: 5.869)
2015 .04
题为Microparticles mediate human papillomavirus type 6 or 11 infection of human macrophages 在 Cellular & Molecular Immunology 杂志上发表。(IF: 8.484)
2015 .02
题为Cell-free tumor microparticle vaccines stimulate dendritic cells via cGAS/STING signaling 在 Cancer Immunology Research 杂志上发表。(IF: 8.728)
2012 .12
题为Delivery of chemotherapeutic drugs in tumourcell-derived microparticles Nature Communications上发表。 (IF: 12.121)
2012.10
2012 .08
2010 .10